Neuropathix, Inc.

NPTX · OTC
Analyze with AI
3/31/2022
12/31/2021
9/30/2021
6/30/2021
Assets
Cash & Equivalents$102$16$6$51
Short-Term Investments$0$0$0$0
Receivables$0$0$35$0
Inventory$0$0$0$0
Other Curr. Assets$6$122$16$11
Total Curr. Assets$108$138$57$62
Property Plant & Equip (Net)$262$69$76$81
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$17$17$17$17
Total NC Assets$279$86$93$98
Other Assets$0$0$0$0
Total Assets$387$225$149$161
Liabilities
Payables$479$486$416$346
Short-Term Debt$1,525$1,404$1,384$1,316
Tax Payable$242$241$241$243
Deferred Revenue$0$113$241$243
Other Curr. Liab.$1,353$739$367$368
Total Curr. Liab.$3,598$2,983$2,649$2,516
LT Debt$585$505$483$404
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,456$723$532$433
Total NC Liab.$2,041$1,228$1,015$836
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,639$4,211$3,664$3,352
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$9$9
Retained Earnings-$18,187-$16,591-$15,834-$15,113
AOCI$0$0$0$0
Other Equity$12,926$12,595$12,311$11,913
Total Equity-$5,252-$3,987-$3,515-$3,192
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$387$225$149$161
Net Debt$2,008$1,893$1,861$1,668
Neuropathix, Inc. (NPTX) Financial Statements & Key Stats | AlphaPilot